Please login to the form below

Not currently logged in
Email:
Password:

antimicrobial resistance

This page shows the latest antimicrobial resistance news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

Europe launches antimicrobial research ‘Accelerator’. A new Antimicrobial Resistance (AMR) Accelerator Programme has been unveiled by the EU and pharma-funded Innovative Medicines Initiative (IMI). ... Pierre Meulien, IMI Executive Director commented:

Latest news

More from news
Approximately 38 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Rules of engagement Rules of engagement

    A 2015 survey by the World Health Organization (WHO) in 12 countries highlighted people’s unfamiliarity with the language of antibiotic resistance. ... Fewer than half of the nearly 10, 000 respondents had heard of the term ‘antimicrobial

  • No incentive for a cure No incentive for a cure

    The stakes are too high for this not to happen. The risk we face from antimicrobial resistance and the current lack of new antibiotics tells us all we need to know

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    The threat of antimicrobial resistance. Why this issue is such a fundamental challenge. ... A look at some of the headline statistics on the antimicrobial resistance (AMR) issue is particularly sobering.

  • Significant figures Significant figures

    us.”. An inhaled formulation of last-resort antibiotic Amikacin, ALIS taps into a need for new antibiotics as well as industry heads towards more joined-up thinking to tackle antimicrobial resistance. ... develop resistance to the macrolide antibiotic,

  • Deal Watch May 2016 Deal Watch May 2016

    Warning that by the year 2050, drug resistant bacteria could kill one person every second across the world, the UK Review on Antimicrobial Resistance recommends a "pay-or-play" system. ... It is suggested that those companies that do not engage in

More from intelligence
Approximately 5 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Antibiotic Resistance: Alarm bells ring louder than ever

    Antibiotic Resistance: Alarm bells ring louder than ever. Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to ... where antibiotics and the threat of

  • Cello Health

    Antibiotic Resistance: Alarm bells ring louder than ever. ... Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics